WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017192581) FORMULATIONS AND TREATMENTS EMPLOYING HYDROXYPYRIDONATE ACTINIDE/LANTHANIDE DECORPORATION AGENTS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/192581    International Application No.:    PCT/US2017/030628
Publication Date: 09.11.2017 International Filing Date: 02.05.2017
IPC:
A61K 31/4425 (2006.01), A61K 31/444 (2006.01), A61P 39/04 (2006.01)
Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; 1111 Franklin Street, 12th Floor Oakland, CA 94607 (US)
Inventors: ABERGEL, Rebecca, J.; (US).
DEBLONDE, Gauthier, J.P.; (US)
Agent: FULLER, Michael, L.; (US)
Priority Data:
62/331,369 03.05.2016 US
62/383,963 06.09.2016 US
Title (EN) FORMULATIONS AND TREATMENTS EMPLOYING HYDROXYPYRIDONATE ACTINIDE/LANTHANIDE DECORPORATION AGENTS
(FR) FORMULATIONS ET TRAITEMENTS AYANT RECOURS À DES HYDROXYPYRIDONATES DÉCORPORANTS D'ACTINIDE/LANTHANIDE
Abstract: front page image
(EN)Provided herein are methods for treating a subject in need of such treatment comprising administering a therapeutically effective amount of one or more pharmaceutical compositions comprising a 1,2-HOPO chelating agent and/or a 3,2-HOPO chelating agent to a subject in need of such treatment. The subject can be one who has been, or will be, exposed to one or more known or unknown actinides and/or lanthanides, or a mixture thereof.
(FR)L'invention concerne un procédé de traitement d'un sujet nécessitant d'un tel traitement, comprenant l'administration d'une quantité thérapeutiquement efficace d'une ou de plusieurs compositions pharmaceutiques comportant un agent chélateur 1,2-HOPO et un agent chélateur 3,2-HOPO à un sujet nécessitant un tel traitement. Le sujet peut être un sujet ayant été, ou amené à être, exposé à un ou plusieurs actinides et/ou lanthanides connus ou inconnus, ou à un mélange de ceux-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)